| Literature DB >> 31681486 |
Dae-Young Kang1, Myeongjin Kim1, Sung-Jo Lee2, In-Woo Cho1, Hyun-Seung Shin1, Jordi Caballé-Serrano3, Jung-Chul Park1.
Abstract
PURPOSE: The aim of this retrospective study was to determine the prevalence of early implant failure using a single implant system and to identify the factors contributing to early implant failure.Entities:
Keywords: Dental implants; Operative surgical procedures; Osseointegration; Risk factors
Year: 2019 PMID: 31681486 PMCID: PMC6819696 DOI: 10.5051/jpis.2019.49.5.287
Source DB: PubMed Journal: J Periodontal Implant Sci ISSN: 2093-2278 Impact factor: 2.614
Descriptive data of the included patients
| Variable | All placed implants (n=1,031) | Early failures (n=35) | |
|---|---|---|---|
| Sex | |||
| Male | 624 (60.5) | 23 (65.7) | |
| Female | 407 (39.5) | 12 (34.3) | |
| Age (yr) | |||
| <40 | 74 (7.2) | 1 (2.9) | |
| 40–49 | 236 (22.9) | 7 (20.0) | |
| 50–59 | 401 (38.9) | 14 (40.0) | |
| 60–69 | 245 (23.8) | 12 (34.3) | |
| ≥70 | 75 (7.3) | 1 (2.9) | |
| Jaw | |||
| Maxilla | 528 (51.2) | 11 (31.4) | |
| Mandible | 503 (48.8) | 24 (68.6) | |
| Position | |||
| Anterior | 106 (10.3) | 3 (8.6) | |
| Posterior | 925 (89.7) | 32 (91.4) | |
| Surgeon | |||
| Faculty member | 640 (62.1) | 11 (31.4) | |
| Resident | 391 (37.9) | 24 (68.6) | |
| Protocol | |||
| 1-stage | 712 (69.1) | 21 (60.0) | |
| 2-stage | 319 (30.9) | 14 (40.0) | |
| Implant diameter (mm) | |||
| 3.5 | 45 (4.4) | 3 (8.6) | |
| 4.0 | 216 (21.0) | 7 (20.0) | |
| 4.5 | 281 (27.3) | 6 (17.1) | |
| 5.0 | 468 (45.4) | 17 (48.6) | |
| 6.0 | 21 (2.0) | 2 (5.7) | |
| Implant length (mm) | |||
| 7.0 | 157 (15.2) | 0 (0.0) | |
| 8.5 | 670 (65.0) | 25 (71.4) | |
| 10.0 | 187 (18.1) | 10 (28.6) | |
| 11.5 | 15 (1.5) | 0 (0.0) | |
| 13.0 | 2 (0.2) | 0 (0.0) | |
| SFE access approach | |||
| None | 809 (78.5) | 31 (88.6) | |
| Crestal | 37 (3.6) | 0 (0.0) | |
| Lateral | 185 (17.9) | 4 (11.4) | |
| Preoperative GBR | |||
| No | 940 (91.2) | 32 (91.4) | |
| Yes | 91 (8.8) | 3 (8.6) | |
| Simultaneous GBR | |||
| No | 717 (69.5) | 26 (74.3) | |
| Yes | 314 (30.5) | 9 (25.7) | |
Data and number (%) values.
GBR: guided bone regeneration, SFE: sinus-floor elevation.
Figure 1Findings of the implant survival analysis. (A) Overall Kaplan-Meier survival estimates for implant-based analysis in the early phase. (B) Kaplan-Meier survival estimates in the early phase grouped according to seniority of the surgeon.
Case list of early implant failures
| Patient ID | Sex | Age (yr) | Diameter (mm) | Length (mm) | No. of tooth | GBR | SFE | Protocol (stages) | Surgeon ID | Remark |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Male | 47 | 3.5 | 8.5 | 42 | Simultaneous | 1 | 1 | ||
| 2 | Male | 38 | 4 | 10 | 14 | 1 | 1 | Signs of infection | ||
| 3 | Male | 43 | 5 | 10 | 26 | Lateral | 2 | 1 | Signs of infection | |
| 5 | 10 | 27 | Lateral | 2 | 1 | Signs of infection | ||||
| 4 | Male | 60 | 4 | 10 | 34 | 1 | 1 | Symptoms of pain and discomfort | ||
| 5 | Male | 74 | 4 | 8.5 | 34 | 1 | 1 | |||
| 6 | Male | 52 | 4 | 8.5 | 14 | Simultaneous | 1 | 2 | ||
| 7 | Male | 45 | 5 | 8.5 | 36 | Simultaneous | 1 | 2 | ||
| 8 | Male | 47 | 5 | 8.5 | 36 | 1 | 2 | |||
| 9 | Female | 43 | 4.5 | 8.5 | 46 | 1 | 2 | Signs of infection | ||
| 10 | Female | 54 | 4.5 | 8.5 | 37 | 1 | 3 | |||
| 11 | Female | 54 | 3.5 | 10 | 31 | Simultaneous | 2 | 6 | ||
| 12 | Male | 63 | 3.5 | 8.5 | 42 | Simultaneous | 1 | 6 | ||
| 13 | Female | 63 | 5 | 8.5 | 36 | Preoperative | 2 | 6 | Proximity of 2 fixtures | |
| 5 | 8.5 | 37 | 2 | 6 | ||||||
| 14 | Male | 54 | 4 | 8.5 | 34 | Preoperative | 2 | 6 | Suspected uncontrolled DM | |
| 5 | 8.5 | 37 | Preoperative | 2 | 6 | |||||
| 15 | Male | 66 | 5 | 8.5 | 37 | 2 | 6 | |||
| 5 | 10 | 37 | 1 | 6 | ||||||
| 16 | Female | 55 | 5 | 8.5 | 16 | Lateral | 1 | 6 | ||
| 17 | Female | 58 | 5 | 8.5 | 16 | 2 | 6 | |||
| 5 | 8.5 | 17 | 2 | 6 | Occlusal contact between healing abutment of 17 implant and tooth 47 | |||||
| 6 | 10 | 27 | 1 | 6 | ||||||
| 18 | Female | 53 | 4.5 | 8.5 | 46 | 1 | 7 | |||
| 19 | Female | 54 | 4.5 | 8.5 | 26 | Simultaneous | 2 | 7 | ||
| 20 | Male | 58 | 5 | 10 | 47 | 1 | 7 | |||
| 21 | Male | 42 | 4 | 8.5 | 34 | 1 | 7 | |||
| 22 | Male | 62 | 5 | 10 | 37 | 1 | 8 | |||
| 23 | Male | 51 | 4 | 8.5 | 14 | 2 | 9 | |||
| 24 | Male | 60 | 4.5 | 8.5 | 35 | 1 | 11 | Suspected uncontrolled DM | ||
| 5 | 8.5 | 36 | 1 | 11 | ||||||
| 4.5 | 8.5 | 45 | Simultaneous | 2 | 11 | |||||
| 5 | 8.5 | 46 | Simultaneous | 2 | 11 | |||||
| 25 | Male | 61 | 5 | 10 | 47 | 1 | 11 | |||
| 26 | Female | 59 | 6 | 8.5 | 17 | Simultaneous | Lateral | 1 | 13 |
GBR: guided bone regeneration, SFE: sinus-floor elevation, DM: diabetes mellitus.
Findings of the univariate and multivariate Cox regression analyses for early implant failure
| Variable | Univariate regression | Multivariate regression* | ||
|---|---|---|---|---|
| cHR (95% CI) | aHR (95% CI) | |||
| Female (reference: male) | 0.89 (0.44–1.81) | 0.752 | ||
| Age | 1.01 (0.98–1.05) | 0.462 | ||
| Mandible (reference: maxilla) | 1.99 (0.84–4.72) | 0.117 | 2.31 (1.12–4.76) | 0.023† |
| Posterior (reference: anterior) | 1.36 (0.32–5.78) | 0.677 | ||
| Resident surgeon (reference: faculty member) | 2.69 (1.27–5.71) | 0.001† | 2.86 (1.37–5.94) | 0.005† |
| 1-stage (reference: 2-stage) | 0.68 (0.33–1.40) | 0.293 | ||
| Implant diameter | 0.98 (0.44–2.21) | 0.966 | ||
| Implant length | 1.36 (0.93–1.99) | 0.108 | 1.33 (0.94–1.90) | 0.112 |
| SFE (reference: none) | 0.66 (0.19–2.36) | 0.527 | ||
| Preoperative GBR (reference: none) | 0.89 (0.27–2.94) | 0.849 | ||
| Simultaneous GBR (reference: none) | 0.63 (0.28–1.42) | 0.266 | ||
cHR: crude hazard ratio, aHR: adjusted hazard ratio, CI: confidence interval, GBR: guided bone regeneration, SFE: sinus-floor elevation.
*Wald test=18.53 for 3 degrees of freedom, P<0.001; †Significant difference.
Distribution and findings of the univariate Cox regression analysis for early implant failure according to individual surgeons
| Surgeon ID | All placed implants (n=1,031) | Early failures (n=35) | cHR | CI | ||
|---|---|---|---|---|---|---|
| Faculty members | ||||||
| 1 (reference) | 406 (39.4) | 6 (17.1) | 1.00 | |||
| 2 | 202 (19.6) | 4 (11.4) | 1.41 | 0.40–5.00 | 0.594 | |
| 3 | 25 (2.4) | 1 (2.9) | 2.85 | 0.34–23.67 | 0.333 | |
| 4 | 4 (0.4) | 0 (0.0) | ||||
| 5 | 3 (0.3) | 0 (0.0) | ||||
| Subtotal | 640 (62.1) | 11 (31.4) | ||||
| Residents | ||||||
| 6 | 108 (10.5) | 12 (34.3) | 8.46 | 3.17–22.56 | <0.001* | |
| 7 | 65 (6.3) | 4 (11.4) | 4.01 | 1.13–14.21 | 0.032* | |
| 8 | 55 (5.3) | 1 (2.9) | 1.11 | 0.13–9.24 | 0.922 | |
| 9 | 44 (4.3) | 1 (2.9) | 1.50 | 0.18–12.48 | 0.707 | |
| 10 | 36 (3.5) | 0 (0.0) | ||||
| 11 | 26 (2.5) | 5 (14.3) | 12.76 | 3.89–41.88 | <0.001* | |
| 12 | 19 (1.8) | 0 (0.0) | ||||
| 13 | 18 (1.7) | 1 (2.9) | 3.65 | 0.44–30.30 | 0.231 | |
| 14 | 15 (1.5) | 0 (0.0) | ||||
| 15 | 5 (0.5) | 0 (0.0) | ||||
| Subtotal | 391 (37.9) | 24 (68.6) | ||||
Data and number (%) values except where indicated otherwise.
cHR: crude hazard ratio, CI: confidence interval.
*Significant difference.